Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine

Despite the worldwide existing regulation banning the use of the recombinant equine growth hormone (reGH) as growth promoter, it is suspected to be used in horseracing to improve performances. Various analytical methods previously developed to screen for its misuse have encountered some limitations...

Full description

Saved in:
Bibliographic Details
Published in:Analytical and bioanalytical chemistry 2009-08, Vol.394 (8), p.2119-2128
Main Authors: Kieken, Fanny, Pinel, Gaud, Antignac, Jean-Philippe, Monteau, Fabrice, Christelle Paris, Anne, Popot, Marie-Agnès, Bonnaire, Yves, Le Bizec, Bruno
Format: Article
Language:English
Subjects:
Analytical Chemistry
Animals
Biochemistry
Characterization and Evaluation of Materials
Chemistry
Chemistry and Materials Science
Chromatographic methods and physical methods associated with chromatography
Chromatography, Liquid - economics
Chromatography, Liquid - methods
Exact sciences and technology
Food Science
Growth Hormone - administration & dosage
Growth Hormone - pharmacology
Growth Hormone - urine
Growth hormones
Horses
Horses - urine
Laboratory Medicine
Mass spectrometry
Mathematical analysis
Metabolome - drug effects
Metabolomics - economics
Metabolomics - methods
Monitoring/Environmental Analysis
Multivariate Analysis
Original Paper
Other chromatographic methods
Recombinant
Reproducibility of Results
Sensitivity and Specificity
Spectrometric and optical methods
Spectrometry, Mass, Electrospray Ionization - economics
Spectrometry, Mass, Electrospray Ionization - methods
Strategy
Urine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite the worldwide existing regulation banning the use of the recombinant equine growth hormone (reGH) as growth promoter, it is suspected to be used in horseracing to improve performances. Various analytical methods previously developed to screen for its misuse have encountered some limitations in terms of detection timeframes, in particular during the first days following reGH administration. A novel strategy involving the characterization of global metabolomic fingerprints in urine samples of non-treated and reGH-treated horses by liquid chromatography-electrospray-high-resolution mass spectrometry (LC-ESI-HRMS) is described and assessed in this paper in order to develop a new screening tool for growth hormone abuse in horseracing. The strategy involves a limited sample preparation of the urine samples and the use of appropriate software for data processing and analysis. As preliminary work, reproducibility of both sample preparation and mass spectrometry (MS) measurements was evaluated in order to demonstrate the reliability of the method. Application of the developed protocol on two horses demonstrated the suitability of the developed strategy and preliminary results showed significant modifications of the metabolome after treatment with reGH. [graphic removed]
ISSN:1618-2642
1618-2650
DOI:10.1007/s00216-009-2912-8